Evaluation of 9-cis retinoic acid (9-CRA.#NSC659722) [alitretinoin] in persistent or recurrent squamous cell carcinoma of the cervix previously treated by chemotherapy

Trial Profile

Evaluation of 9-cis retinoic acid (9-CRA.#NSC659722) [alitretinoin] in persistent or recurrent squamous cell carcinoma of the cervix previously treated by chemotherapy

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Dec 2005

At a glance

  • Drugs Alitretinoin (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top